1. Implement the capacity-building action plan for the Cartagena Protocol on Biosafety and the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress
2. Carry out the Implementation Plan for the Cartagena Protocol on Biosafety
3. Raise awareness and educate the public on biosafety issues
4. Strengthen the regulatory framework and harmonize regulations with other regulatory agencies
5. Increase capacity to conduct monitoring and surveillance activities
6. Review National Biotechnology Policy of 2005 to ensure sharing of results and benefits from Biotechnology research using genetic resources
    

These considerations were taken into account through a participatory and consultative process. The process involved an inception workshop, a series of stakeholder consultations, technical working group meetings, and validation workshops. The process was coordinated by the Ministry of Environment, Climate and Wildlife (MECW), through the Department of Wildlife and Forestry Resources Management.

Contribution to KM-GBF Global Goals
 

1. Global Goal A – Ecosystem and Species Integrity

• Protects biodiversity, ecosystems and species from potential adverse impacts of living modified organisms (LMOs) and biotechnology through strengthened biosafety risk assessment, monitoring, surveillance and liability and redress mechanisms.
• Prevents unintended harm to native species, genetic diversity and ecosystems by enforcing precautionary biosafety measures consistent with Article 8(g) of the Convention on Biological Diversity and the Cartagena Protocol on Biosafety.
• Enhances early detection, response and remediation of biosafety incidents, reducing long-term ecological risks associated with biotechnology use and transboundary movement of LMOs.

2. Global Goal B – Sustainable Use and Nature’s Contributions to People

• Enables the safe and responsible use of biotechnology in agriculture, health, industry and environmental management, ensuring that technological innovation contributes positively to food security, livelihoods and sustainable development.
• Balances innovation with environmental protection by embedding biosafety considerations into national development planning and sectoral decision-making.
• Builds public confidence in biotechnology through transparent decision-making, public awareness and access to information, supporting informed societal choices and sustainable use of biological resources.

3. Global Goal C – Fair and Equitable Benefit-Sharing

• Strengthens frameworks for the fair and equitable sharing of benefits arising from biotechnology research and development using genetic resources, in line with Article 19 of the CBD and the Nagoya Protocol.
• Ensures that benefits from biotechnology are shared with Indigenous Peoples and Local Communities (IPLCs), research institutions and other knowledge holders whose genetic resources and associated traditional knowledge contribute to innovation.
• Promotes Access and Benefit-Sharing (ABS)-compliant biotechnology research by revising national biotechnology policy, strengthening institutional mechanisms, and enhancing compliance and reporting to the ABS Clearing-House.

4. Global Goal D – Means of Implementation and Enabling Conditions

• Strengthens national biosafety governance through updated legal, regulatory and administrative frameworks, including harmonisation across regulatory agencies and alignment with international biosafety instruments.
• Builds institutional, technical and human capacity for biosafety risk assessment, monitoring, surveillance, enforcement, liability and redress.
• Enhances coordination, reporting and information exchange through operationalisation of the Biosafety Clearing-House and regular reporting to international conventions and protocols.
• Mobilises sustained financial resources and investments to support biosafety infrastructure, laboratories, surveillance systems, education, public awareness and policy implementation.

1. Policy, advocacy and awareness.
2. Review of existing regulations to address emerging technologies.